Joint CDRH (Center for Devices and Radiological Health) and State Quality Assurance Surveys in Nuclear Medicine: Phase 2 - Radiopharmaceuticals

摘要

The report discusses survey results on aspects of the quality assurance of radio-pharmaceuticals from 180 nuclear medicine facilities in the United States. Data was collected from facilities in 8 states. Demographic information about nuclear medicine operations and quality assurance programs was gathered by state radiation control program personnel. The data collected from the survey show an incomplete acceptance of quality assurance practices for radiopharmaceuticals. Most of the facilities in the survey indicated that because an inferior radiopharmaceutical was prepared so infrequently, they did not believe it was cost-effective to perform extensive quality assurance testing. The Center for Devices and Radiological Health hopes that the information from the survey will stimulate nuclear medicine professionals and their organizations to encourage appropriate testing of all radiopharmaceuticals.